Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M96.3Revenue $M11.2Net Margin (%)-122.6Altman Z-Score-11.2
Enterprise Value $M57.5EPS $-0.2Operating Margin %-125.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.7Pre-tax Margin (%)-122.6Higher ROA y-yY
Price/Book3.310-y EBITDA Growth Rate %-16.5Quick Ratio3.7Cash flow > EarningsN
Price/Sales8.55-y EBITDA Growth Rate %-6.7Current Ratio3.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-27.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-40.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M62.9ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARQL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARQLFirst Eagle Investment 2015-06-30 Add0.01%$1.53 - $2.26
($1.93)
$ 1.53-21%Add 52.45%8,719,968
ARQLFirst Eagle Investment 2015-03-31 Add0.01%$1.1 - $2.46
($1.59)
$ 1.53-4%Add 28.69%5,719,968
ARQLFirst Eagle Investment 2014-12-31 Add$1.06 - $1.36
($1.18)
$ 1.5330%Add 56.31%4,444,899
ARQLGeorge Soros 2014-09-30 Sold Out $1.12 - $1.56
($1.31)
$ 1.5317%Sold Out0
ARQLGeorge Soros 2014-06-30 Buy $1.34 - $2.04
($1.56)
$ 1.53-2%New holding78,600
ARQLFirst Eagle Investment 2013-09-30 Reduce-0.01%$2.15 - $2.79
($2.51)
$ 1.53-39%Reduce -26.47%3,314,553
ARQLFirst Eagle Investment 2012-12-31 Add0.01%$2.18 - $2.95
($2.6)
$ 1.53-41%Add 49.46%4,539,651
ARQLFirst Eagle Investment 2012-06-30 Add0.01%$5.53 - $8.16
($6.56)
$ 1.53-77%Add 28.79%2,673,589
ARQLGeorge Soros 2011-12-31 Sold Out -0.0014%$4.58 - $6.05
($5.55)
$ 1.53-72%Sold Out0
ARQLGeorge Soros 2011-09-30 Add$4.11 - $6.64
($5.2)
$ 1.53-71%Add 54.79%16,100
ARQLFirst Eagle Investment 2011-03-31 Add0.03%$5.85 - $6.95
($6.41)
$ 1.53-76%Add 84.22%1,693,456
ARQLGeorge Soros 2011-03-31 Buy $5.85 - $6.95
($6.41)
$ 1.53-76%New holding12,200
ARQLFirst Eagle Investment 2010-12-31 Add0.01%$4.95 - $6.14
($5.53)
$ 1.53-72%Add 29.43%919,266
ARQLFirst Eagle Investment 2010-03-31 Reduce-0.03%$3.04 - $3.92
($3.45)
$ 1.53-56%Reduce -56.47%685,266
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARQL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ARQL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LOBERG MICHAEL DDirector 2015-12-17Buy3,719$2.16-29.17view
LOBERG MICHAEL DDirector 2015-12-16Buy1,231$2.14-28.5view
Pucci PaoloCEO 2015-12-15Buy1,283$2.16-29.17view
Pucci PaoloCEO 2015-12-11Buy1,108$2.1-27.14view
ZENNER PATRICK JDirector 2015-12-11Buy2,300$2.15-28.84view
Pucci PaoloCEO 2015-12-10Buy7,609$2.1-27.14view
ZENNER PATRICK JDirector 2015-03-11Buy10,625$2.32-34.05view
Pucci PaoloCEO 2014-11-20Buy5,000$1.2621.43view
ZENNER PATRICK JDirector 2014-11-14Buy20,830$1.227.5view
Messenger William GDirector 2014-11-14Buy8,500$1.2126.45view

Quarterly/Annual Reports about ARQL:

News about ARQL:

Articles On GuruFocus.com
Jean-Marie Eveillard Increases Stakes in Cancer Therapeutics Company Arqule Inc May 05 2015 
Jean-Marie Eveillard Adds to Stake in Arqule Inc. May 03 2015 
ArQule Inc. Reports Operating Results (10-Q) Nov 09 2010 
ArQule Inc. Reports Operating Results (10-Q) Aug 04 2010 
ArQule Inc. Reports Operating Results (10-Q) May 06 2010 
ArQule Inc. (ARQL) CEO Paolo Pucci buys 5,000 Shares Nov 13 2009 
ArQule Inc. Reports Operating Results (10-Q) Aug 07 2009 
ArQule Inc. (ARQL) CEO Paolo Pucci buys 2,500 Shares May 15 2009 
ArQule Inc. Reports Operating Results (10-Q) May 08 2009 

More From Other Websites
ArQule To Report First Quarter 2016 Financial Results On May 4, 2016 May 03 2016
ArQule To Report First Quarter 2016 Financial Results On May 4, 2016 Apr 20 2016
ArQule to Present at the 15th Annual Needham Healthcare Conference on April 12, 2016 Apr 18 2016
ARQULE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Apr 14 2016
ArQule to Present at the 15th Annual Needham Healthcare Conference on April 12, 2016 Apr 05 2016
ETF’s with exposure to ArQule, Inc. : March 28, 2016 Mar 28 2016
ARQULE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 22 2016
Daiichi Sankyo and ArQule Announce Continuation of METIV-HCC Phase 3 Study of Tivantinib in... Mar 22 2016
Pfizer Inc (PFE) Reports 4.4% Position in Arqule Inc (ARQL) Mar 18 2016
ETF’s with exposure to ArQule, Inc. : March 14, 2016 Mar 14 2016
ArQule, Inc. :ARQL-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 14 2016
ARQULE INC Financials Mar 08 2016
ARQULE INC Files SEC form 8-K/A, Other Events Mar 04 2016
Edited Transcript of ARQL earnings conference call or presentation 29-Feb-16 2:00pm GMT Feb 29 2016
ArQule Inc Earnings Call scheduled for 9:00 am ET today Feb 29 2016
ARQULE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Feb 29 2016
ArQule reports 4Q loss Feb 29 2016
ArQule reports 4Q loss Feb 29 2016
Q4 2015 ArQule Inc Earnings Release - Before Market Open Feb 29 2016
ArQule Reports Fourth Quarter and Full Year 2015 Financial Results Feb 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)